Table A1.
Sodium Group | Entire Cohort (N = 38 722) | Excluding all CVD (N = 35 731) | Excluding Hypertension (N = 22 417) | Excluding Diabetes (N = 20 378) |
---|---|---|---|---|
Quintile 1 (0.06‐2.6 g/d) | 32.6 (30.2 to 35.0) | 32.3 (29.8 to 34.8) | 33.3 (30.2 to 36.4) | 32.3 (29.1 to 35.6) |
Quintile 2 (2.6‐3.0 g/d) | 10.0 (8.1 to 11.9) | 10.1 (8.1 to 12.2) | 9.1 (6.8 to 11.4) | 8.7 (6.2 to 11.1) |
Quintile 3 (3.0‐3.4 g/d) | (Ref) | (Ref) | (Ref) | (Ref) |
Quintile 4 (3.4‐4.0 g/d) | −10.7 (−12.4 to −9.0) | −10.5 (−12.3 to −8.7) | −10.8 (−13.0 to −8.6) | −10.6 (−12.9 to −8.4) |
Quintile 5 (4.0‐29.3 g/d) | −23.0 (−24.6 to −21.4) | −23.2 (−25.0 to −21.5) | −22.4 (−24.4 to −20.4) | −22.2 (−24.4 to −20.0) |
All P values are <.001 for comparison of each sodium quintile to sodium quintile 3 (Reference Group).
Numbers represent the regression coefficient with the 95% confidence interval in parentheses.